Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 569-574

  Rizza, Stefano ^a   Tesauro, Manfredi ^a   Cardillo, Carmine ^b   Galli, Angelica ^a   Iantorno, Micaela ^c   Gigli, Fabrizio ^a   Sbraccia, Paolo ^a   Federici, Massimo ^a   Quon, Michael J ^c   Lauro, Davide ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endothelial function; Fish oil; Inflammation; TNF alpha; Type 2 diabetes

Indexed keywords

ADIPONECTIN; FISH OIL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ENDOTHELIUM; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349410386     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.006     Document Type: Article

References (36)

1. Kathiresan S., Gona P., Larson M.G., et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation 113 (2006) 938-945
2. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., and Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115 (2007) 2390-2397
3. Balletshofer B.M., Rittig K., Enderle M.D., et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
4. Goldfine A.B., Beckman J.A., Betensky R.A., et al. Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol 47 12 (2006) 2456-2461
5. Tesauro M., Rizza S., Iantorno M., et al. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism 56 3 (2007) 413-419
6. Iellamo F., Tesauro M., Rizza S., et al. Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects. Hypertension 48 3 (2006) 418-423
7. Scuteri A., Tesauro M., Rizza S., et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 18 5 (2008) 349-356
8. Osei K., Gaillard T., Kaplow J., Bullock M., and Schuster D. Effects of rosiglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism 53 12 (2004) 1552-1557
9. Levin K., Hother-Nielsen O., Henriksen J.E., and Beck-Nielsen H. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes. Diabetes Care 27 1 (2004) 148-154
10. McSorley P.T., Bell P.M., Young I.S., et al. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med 22 6 (2005) 703-710
11. De Aguiar L.G., Bahia L.R., Villela N., et al. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes Care 29 5 (2006) 1083-1089
12. Rallidis L.S., Paschos G., Liakos G.K., et al. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167 (2003) 237-242
13. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones J.H.C., and Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. JACC 35 2 (2000) 265-270
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl. 1):S5-20.
15. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
16. Meigs J.B., O'donnell C.J., Tofler G.H., et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55 2 (2006) 530-537
17. Schiano V., Laurenzano E., Revetti G., et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr 27 (2008) 241-247
18. Tsitouras P.D., Gucciardo F., Salbe A.D., Heward C., and Haeman S.M. High omega-3 intake improves insulin sensitivity and reduces CRP and IL-6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40 (2008) 199-205
19. Lo C.J., Chiu K.C., Fu M., Lo R., and Shelton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFκB activity. J Surg Res 82 (1999) 216-222
20. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., and Espat N.J. NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol 284 (2003) L84-L89
21. Hotamisligil G.S. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54 (2005) S73-S78
22. Wright S.A., O'Prey F.M., McHenry M.T., et al. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 67 6 (2008) 841-848
23. Kathryn E., Wellen G., and Hotamisligil. Obesity-induced inflammatory changes in adipose-tissue. J Clin Invest 112 (2003) 1785-1788
24. Federici M., Hribal M.L., Menghini R., et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 115 (2005) 3494-3505
25. Salem Jr. N., Wegher B., Mena P., and Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci 93 1 (1996) 49-54
26. Stillwell W., and Wassall S.R. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 126 1 (2003) 1-27
27. Di Rocco P., Manco M., Rosa G., Greco A.V., and Mingrone G. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes Res 12 (2004) 734-739
28. Tesauro M., Schinzari F., Rovella V., et al. TNF-{alpha} antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 31 7 (2008) 1439-1441 [Epub ahead of print]
29. Yosefy C., Viskoper J.R., Laszt A., et al. The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 61 2 (1999) 83-87
30. Sirtori C.R., Crepaldi G., Manzato E., et al. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alteration. Atherosclerosis 137 (1998) 419-427
31. Dunstan D.W., Mori T.A., Puddey I.B., et al. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care 20 (1997) 913-921
32. Axelrod L., Camuso J., Williams E., et al. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM: a randomized, prospective, double-blind, controlled study. Diabetes Care 17 (1994) 37-44
33. Tilg H., and Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14 3-4 (2008) 222-231
34. Psota T.L., Gebauer S.K., and Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 21 98(4A) (2006) 3i-18i
35. Investigators G.-HF., Tavazzi L., Maggioni A.P., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 9645 (2008) 1195-1196
36. Mita T., Watada H., Ogihara T., et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 191 1 (2007) 162-167